CoChat

mGluR2 versus mGluR3 Metabotropic Glutamate Receptors in Primate Dorsolateral Prefrontal Cortex: Postsynaptic mGluR3 Strengthen Working Memory Networks

Open access
Jin, Lu E, Wang, Min, Galvin, Veronica C, Lightbourne, Taber C, Conn, Peter Jeffrey, Arnsten, Amy F T, Paspalas, Constantinos D · 2018 · Cerebral Cortex
Cited by 111

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

The newly evolved circuits in layer III of primate dorsolateral prefrontal cortex (dlPFC) generate the neural representations that subserve working memory. These circuits are weakened by increased cAMP-K+ channel signaling, and are a focus of pathology in schizophrenia, aging, and Alzheimer's disease. Cognitive deficits in these disorders are increasingly associated with insults to mGluR3 metabotropic glutamate receptors, while reductions in mGluR2 appear protective. This has been perplexing, as mGluR3 has been considered glial receptors, and mGluR2 and mGluR3 have been thought to have similar functions, reducing glutamate transmission. We have discovered that, in addition to their astrocytic expression, mGluR3 is concentrated postsynaptically in spine synapses of layer III dlPFC, positioned to strengthen connectivity by inhibiting postsynaptic cAMP-K+ channel actions. In contrast, mGluR2 is principally presynaptic as expected, with only a minor postsynaptic component. Functionally, increase in the endogenous mGluR3 agonist, N-acetylaspartylglutamate, markedly enhanced dlPFC Delay cell firing during a working memory task via inhibition of cAMP signaling, while the mGluR2 positive allosteric modulator, BINA, produced an inverted-U dose-response on dlPFC Delay cell firing and working memory performance. These data illuminate why insults to mGluR3 would erode cognitive abilities, and support mGluR3 as a novel therapeutic target for higher cognitive disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cercor/bhx005

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Research works printed but not linked: 32

  1. Aronica, 2003, Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins, Eur J Neurosci, 17, 2106, 10.1046/j.1460-9568.2003.02657.x · DOI · Paper page
  2. Benneyworth, 2007, A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis, Mol Pharmacol, 72, 477, 10.1124/mol.107.035170 · DOI
  3. Bishop, 2015, Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia, Psychopharmacology, 232, 145, 10.1007/s00213-014-3649-4 · DOI
  4. Caraci, 2011, Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective, Mol Pharmacol, 79, 618, 10.1124/mol.110.067488 · DOI
  5. Chang, 2015, Evaluation of relationship between GRM3 polymorphisms and cognitive function in schizophrenia of Han Chinese, Psychiatry Res, 229, 1043, 10.1016/j.psychres.2015.06.012 · DOI
  6. Colantuoni, 2008, Age-related changes in the expression of schizophrenia susceptibility genes in the human prefrontal cortex, Brain Struct Funct, 213, 255, 10.1007/s00429-008-0181-5 · DOI
  7. Corti, 2007, Altered dimerization of metabotropic glutamate receptor 3 in schizophrenia, Biol Psychiatry, 62, 747, 10.1016/j.biopsych.2006.12.005 · DOI
  8. Corti, 2007, The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection, J Neurosci, 27, 8297, 10.1523/JNEUROSCI.1889-07.2007 · DOI · Paper page
  9. Durand, 2011, Reduced cAMP, Akt activation and p65-c-Rel dimerization: mechanisms involved in the protective effects of mGluR3 agonists in cultured astrocytes, PLoS One, 6, e22235, 10.1371/journal.pone.0022235 · DOI
  10. Egan, 2004, Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia, Proc Natl Acad Sci U S A, 101, 12604, 10.1073/pnas.0405077101 · DOI · Paper page
  11. Gao, 2015, Mice lacking glutamate carboxypeptidase II develop normally, but are less susceptible to traumatic brain injury, J Neurochem, 134, 340, 10.1111/jnc.13123 · DOI
  12. Ghose, 2009, Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action?, Am J Psychiatry, 166, 812, 10.1176/appi.ajp.2009.08091445 · DOI · Paper page
  13. Hadley, 2014, The impact of the metabotropic glutamate receptor and other gene family interaction networks on autism, Nat Commun, 5, 4074, 10.1038/ncomms5074 · DOI · Paper page
  14. Harrison, 2008, The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia, J Psychopharmacol, 22, 308, 10.1177/0269881108089818 · DOI · Paper page
  15. Jablensky, 2011, Polymorphisms associated with normal memory variation also affect memory impairment in schizophrenia, Genes Brain Behav, 10, 410, 10.1111/j.1601-183X.2011.00679.x · DOI
  16. Janczura, 2013, NAAG peptidase inhibitors and deletion of NAAG peptidase gene enhance memory in novel object recognition test, Eur J Pharmacol, 701, 27, 10.1016/j.ejphar.2012.11.027 · DOI
  17. Jin, 2016, mGluR2/3 mechanisms in primate dorsolateral prefrontal cortex: evidence for both presynaptic and postsynaptic actions, Mol Psychiatry
  18. Kim, 2010, Group II metabotropic glutamate receptor stimulation triggers production and release of Alzheimer's amyloid(beta)42 from isolated intact nerve terminals, J Neurosci, 30, 3870, 10.1523/JNEUROSCI.4717-09.2010 · DOI · Paper page
  19. Kinoshita, 2015, Effect of metabotropic glutamate receptor-3 variants on prefrontal brain activity in schizophrenia: An imaging genetics study using multi-channel near-infrared spectroscopy, Prog Neuropsychopharmacol Biol Psychiatry, 62, 14, 10.1016/j.pnpbp.2015.04.006 · DOI
  20. Kordi-Tamandani, 2013, Evaluation of hypermethylation and expression pattern of GMR2, GMR5, GMR8, and GRIA3 in patients with schizophrenia, Gene, 515, 163, 10.1016/j.gene.2012.10.075 · DOI
  21. Mössner, 2008, Further evidence for a functional role of the glutamate receptor gene GRM3 in schizophrenia, Eur Neuropsychopharmacol, 18, 768, 10.1016/j.euroneuro.2008.05.007 · DOI
  22. Mounce, 2014, Association of GRM3 polymorphism with white matter integrity in schizophrenia, Schizophr Res, 155, 8, 10.1016/j.schres.2014.03.003 · DOI
  23. Neale, 2011, Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family, J Neurochem, 118, 490, 10.1111/j.1471-4159.2011.07338.x · DOI · Paper page
  24. O'Brien, 2014, The functional GRM3 Kozak sequence variant rs148754219 affects the risk of schizophrenia and alcohol dependence as well as bipolar disorder, Psychiatr Genet, 24, 277, 10.1097/YPG.0000000000000050 · DOI
  25. Ohishi, 1998, Distribution of a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat and mouse: an immunohistochemical study with a monoclonal antibody, Neurosci Res, 30, 65, 10.1016/S0168-0102(97)00120-X · DOI · Paper page
  26. Paspalas, 2013, Constellation of HCN Channels and cAMP regulating proteins in dendritic spines of the primate prefrontal cortex: potential substrate for working memory deficits in schizophrenia, Cereb Cortex, 23, 1643, 10.1093/cercor/bhs152 · DOI · Paper page
  27. Perlstein, 2001, Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia, Am J Psychiatry, 158, 1105, 10.1176/appi.ajp.158.7.1105 · DOI · Paper page
  28. Petralia, 1996, The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations, Neuroscience, 71, 949, 10.1016/0306-4522(95)00533-1 · DOI · Paper page
  29. Rahn, 2012, Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis, Proc Natl Acad Sci U S A, 109, 20101, 10.1073/pnas.1209934109 · DOI · Paper page
  30. Sartorius, 2008, Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP, Neuropsychopharmacology, 33, 2626, 10.1038/sj.npp.1301669 · DOI
  31. Tamaru, 2001, Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites, Neuroscience, 106, 481, 10.1016/S0306-4522(01)00305-0 · DOI · Paper page
  32. Young-Collier, 2012, The dying of the light: mitochondrial failure in Alzheimer's disease, J Alzheimers Dis, 28, 771, 10.3233/JAD-2011-111487 · DOI · Paper page

Cited by

See all 111

Metadata

Authors
Jin, L. E., Wang, M., Galvin, V. C., Lightbourne, T. C., Conn, P. J., Arnsten, A. F. T., & Paspalas, C. D.
Venue
Cerebral Cortex
Published
2017-01-20
Volume
28
Issue
3
Pages
974-987
ISSN
  • 1047-3211 (ISSN-L)
  • 1460-2199
OpenAlex
W2573828241
Cited by
111
References
13
FWCI
3.99
Type
journal article
Language
en
Open access
bronze
Funders
Public Health Service (R01AG043430-02, R01MH100064-01A1)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: mGluR2 versus mGluR3 Metabotropic Glutamate Receptors in Primate Dorsolateral Prefrontal Cortex: Postsynaptic mGluR3 Strengthen Working Memory Networks. https://app.cochat.ai/papers/10.1093/cercor/bhx005
The paper
Jin, L. E., Wang, M., Galvin, V. C., Lightbourne, T. C., Conn, P. J., Arnsten, A. F. T., & Paspalas, C. D. (2018). mGluR2 versus mGluR3 Metabotropic Glutamate Receptors in Primate Dorsolateral Prefrontal Cortex: Postsynaptic mGluR3 Strengthen Working Memory Networks. Cerebral Cortex. https://doi.org/10.1093/cercor/bhx005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.